|
1
|
Hirohata T, Ishii Y and Matsuno A:
Treatment of pituitary carcinomas and atypical pituitary adenomas:
A review. Neurol Med Chir (Tokyo). 54:966–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciric I, Rosenblatt S, Kerr W Jr, Lamarca
F, Pierce D and Baumgartner C: Perspective in pituitary adenomas:
An end of the century review of tumorigenesis, diagnosis and
treatment. Clin Neurosurg. 47:99–111. 2000.PubMed/NCBI
|
|
3
|
Ozgen T, Oruckaptan HH, Ozcan OE and
Acikgoz B: Prolactin secreting pituitary adenomas: Analysis of 429
surgically treated patients, effect of adjuvant treatment
modalities and review of the literature. Acta Neurochir (Wien).
141:1287–1294. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landolt AM, Minder H, Osterwalder V and
Landolt TA: Bromocriptine reduces the size of cells in
prolactin-secreting pituitary adenomas. Experientia. 39:625–626.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laws ER Jr, Thorner MO and Vance ML:
Bromocriptine therapy for prolactin-secreting pituitary adenomas.
Neurosurg Focus. 1:e4discussion 1p following e6. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bergström M, Muhr C, Lundberg PO,
Bergström K, Gee AD, Fasth KJ and Långström B: Rapid decrease in
amino acid metabolism in prolactin-secreting pituitary adenomas
after bromocriptine treatment: A PET study. J Comput Assist Tomogr.
11:815–819. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JO, Ma R, Akagami R, McKenzie M,
Johnson M, Gete E and Nichol A: Long-term outcomes of fractionated
stereotactic radiation therapy for pituitary adenomas at the BC
Cancer Agency. Int J Radiat Oncol Biol Phys. 87:528–533. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elson A, Bovi J, Kaur K, Maas D, Sinson G
and Schultz C: Effect of treatment modality on the
hypothalamic-pituitary function of patients treated with radiation
therapy for pituitary adenomas: Hypothalamic dose and endocrine
outcomes. Front Oncol. 4:732014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Casanueva FF, Molitch ME, Schlechte JA,
Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A,
Fahlbusch R, et al: Guidelines of the Pituitary Society for the
diagnosis and management of prolactinomas. Clin Endocrinol (Oxf).
65:265–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sahoo JP, Kamalanathan S, Parida PK and
Pillai V: A giant prolactinoma with nasopharyngeal extension
presenting with nasal blockage and epistaxis. BMJ case reports.
2015:2015. View Article : Google Scholar
|
|
11
|
Nakajima T, Tamura T, Kuroki M, Tanaka R
and Hayashi H: A case of prolactinoma presenting with CSF
rhinorrhea and CSF otorrhea during bromocriptine therapy. No
Shinkei Geka. 20:1091–1095. 1992.(In Japanese). PubMed/NCBI
|
|
12
|
Little AS: Repair of cerebrospinal fluid
fistula from an invasive skull base prolactinoma using a septal
mucosal vascularized flap: Technical case report. J Neurol Surg A
Cent Eur Neurosurg. 74(Suppl 1): e50–e53. 2013.PubMed/NCBI
|
|
13
|
Sunil B, Reddy A, Bryant N, Young DW and
Ashraf AP: Invasive giant prolactinoma presenting as a nasal polyp.
J Pediatr. 162:435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Webster J: Dopamine agonist therapy in
hyperprolactinemia. J Reprod Med. 44(Suppl 12): S1105–S1110.
1999.
|
|
15
|
Acharya SV, Gopal RA, Menon PS, Bandgar TR
and Shah NS: Giant prolactinoma and effectiveness of medical
management. Endocr Pract. 16:42–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schettini G, Lombardi G, Merola B, Miletto
P, Fariello C, Cirillo S, Fusco R and Lancranjan I: Effectiveness
of a single injectable dose of bromocriptine long acting in the
treatment of macroprolactinomas. J Endocrinol Invest. 11:47–51.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mroueh AM and Siler-Khodr TM:
Bromocryptine therapy in cases of amenorrhea-galactorrhea. Am J
Obstet Gynecol. 127:291–298. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tyson D, Reggiardo D, Sklar C and David R:
Prolactin-secreting macroadenomas in adolescents. Response to
bromocriptine therapy. Am J Dis Child. 147:1057–1061. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Palmeri CM, Petiti JP, del Sosa LV,
Gutiérrez S, De Paul AL, Mukdsi JH and Torres AI: Bromocriptine
induces parapoptosis as the main type of cell death responsible for
experimental pituitary tumor shrinkage. Toxicol Appl Pharmacol.
240:55–65. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liuzzi A, Chiodini PG, Dallabonzana D,
Oppizzi G and Verde GG: Medical treatment of pituitary adenomas:
Effects on tumor growth. J Endocrinol Invest. 8:273–281. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sharma M, Ambekar S, Sonig A and Nanda A:
Factors predicting the development of new onset post-operative
Hydrocephalus following trans-sphenoidal surgery for pituitary
adenoma. Clin Neurol Neurosurg. 115:1951–1954. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frank G, Pasquini E and Mazzatenta D:
Extended transsphenoidal approach. J Neurosurg. 95:917–918.
2001.PubMed/NCBI
|
|
23
|
Cappabianca P, Cavallo LM, Esposito F, De
Divitiis O, Messina A and De Divitiis E: Extended endoscopic
endonasal approach to the midline skull base: The evolving role of
transsphenoidal surgery. Adv Tech Stand Neurosurg. 33:151–199.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grabenbauer GG, Fietkau R, Buchfelder M,
Meyer M, Baumann J, Hensen J, Rummelt V, Fahlbusch R and Sauer R:
Hormonally inactive hypophyseal adenomas: The results and late
sequelae after surgery and radiotherapy. Strahlenther Onkol.
172:193–197. 1996.(In German). PubMed/NCBI
|
|
25
|
Goyal N, Borkar SA, Agrawal D and
Mahapatra AK: Pituitary adenoma presenting with cerebrospinal fluid
rhinorrhea as the sole symptom. Neurol India. 60:307–308. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perrin G, Stevenaert A and Jouanneau E:
Technical aspects and surgical strategy for removal of corticotroph
pituitary adenoma. Neurochirurgie. 48:186–214. 2002.(In French).
PubMed/NCBI
|
|
27
|
Gondim JA, Almeida JP, de Albuquerque LA,
Gomes E, Schops M and Mota JI: Endoscopic endonasal transsphenoidal
surgery in elderly patients with pituitary adenomas. J Neurosurg.
123:31–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berkmann S, Schlaffer S, Nimsky C,
Fahlbusch R and Buchfelder M: Intraoperative high-field MRI for
transsphenoidal reoperations of nonfunctioning pituitary adenoma. J
Neurosurg. 121:1166–1175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mehta GU, Bakhtian KD and Oldfield EH:
Effect of primary empty sella syndrome on pituitary surgery for
Cushing's disease. J Neurosurg. 121:518–526. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berker M, Hazer DB, Yucel T, Gurlek A,
Cila A, Aldur M and Onerci M: Complications of endoscopic surgery
of the pituitary adenomas: Analysis of 570 patients and review of
the literature. Pituitary. 15:288–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho JM, Ahn JY, Chang JH and Kim SH:
Prevention of cerebrospinal fluid rhinorrhea after transsphenoidal
surgery by collagen fleece coated with fibrin sealant without
autologous tissue graft or postoperative lumbar drainage.
Neurosurgery. 68:130–136. 2011.PubMed/NCBI
|
|
32
|
Lehman NL, Horoupian DS and Harsh GR IV:
Synchronous subarachnoid drop metastases from a pituitary adenoma
with multiple recurrences. Case report. J Neurosurg. 98:1120–1123.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim EH, Ku CR, Lee EJ and Kim SH:
Extracapsular en bloc resection in pituitary adenoma surgery.
Pituitary. 18:397–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanaka S, Link MJ, Brown PD, Stafford SL,
Young WF Jr and Pollock BE: Gamma knife radiosurgery for patients
with prolactin-secreting pituitary adenomas. World Neurosurg.
74:147–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wollesen F and Bendsen BB: Effect rates of
different modalities for treatment of prolactin adenomas. Am J Med.
78:114–122. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dai WD, Liu WH and Zhang DL: One
hemodialysis patient with headache, blurred vision and hypotension
induced by pituitary prolactinoma. Chin Med J (Engl).
125:2787–2789. 2012.PubMed/NCBI
|
|
37
|
Domingue ME, Devuyst F, Alexopoulou O,
Corvilain B and Maiter D: Outcome of prolactinoma after pregnancy
and lactation: A study on 73 patients. Clin Endocrinol (Oxf).
80:642–648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qu X, Wang M, Wang G, Han T, Mou C, Han L,
Jiang M, Qu Y, Zhang M, Pang Q and Xu G: Surgical outcomes and
prognostic factors of transsphenoidal surgery for prolactinoma in
men: A single-center experience with 87 consecutive cases. Eur J
Endocrinol. 164:499–504. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Landolt AM, Keller PJ, Froesch ER and
Mueller J: Bromocriptine: Does it jeopardise the result of later
surgery for prolactinomas? Lancet. 2:657–658. 1982. View Article : Google Scholar : PubMed/NCBI
|
